Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 12/31/2019 (updated monthly) $1,203.8 (M)
Net Assets - Advisor ClassAs of 12/31/2019 (updated monthly) $164.6 (M)
P/E Ratio (12-mo Forward)As of 12/31/2019 (updated monthly) 17.07
P/B RatioAs of 12/31/2019 (updated monthly) 6.17

Positions As of 12/31/2019

Portfolio Details

Asset AllocationAs of 12/31/2019

[name] [value]
Equity 96.19%
Cash & Cash Equivalents 3.81%

Geographic BreakdownAs of 12/31/2019

No chart available for this data.
[name] [value]
United States 82.68%
Cash & Cash Equivalents 3.81%
Netherlands 3.71%
United Kingdom 3.34%
Denmark 2.98%
Canada 1.83%
Switzerland 0.84%
Germany 0.82%

sector breakdownAs of 12/31/2019

[name] [value]
Biotechnology 79.06%
Pharmaceuticals 12.28%
Life Sciences Tools & Services 4.85%
Cash & Cash Equivalents 3.81%

TOP TEN HOLDINGSAs of 12/31/2019

46.57%
Other
0% 100%
[holdings-table-heading]
AMGEN INC 7.04%
VERTEX PHARMACEUTICALS INC 6.58%
GILEAD SCIENCES INC 5.63%
ILLUMINA INC 4.85%
BIOGEN INC 4.67%
REGENERON PHARMACEUTICALS INC 4.03%
IOVANCE BIOTHERAPEUTICS INC 3.83%
DECIPHERA PHARMACEUTICALS INC 3.46%
GW PHARMACEUTICALS PLC 3.34%
HERON THERAPEUTICS INC 3.14%